Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Revive Therapeutics
(OTCQB:RVVTF)
Intraday
$0.0211
-0.0014
[-6.22%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.0211
-0.0014
[-6.22%]
At close: Mar 28
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Revive Therapeutics Stock (OTC:RVVTF)
Revive Therapeutics Stock (OTC: RVVTF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 05, 2023
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
Lara Goldstein
-
Apr 5, 2023, 9:57AM
Monday, April 03, 2023
MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update
Lara Goldstein
-
Apr 3, 2023, 3:46PM
Tuesday, March 28, 2023
Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
Lara Goldstein
-
Mar 28, 2023, 2:31PM
Monday, February 13, 2023
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
Lara Goldstein
-
Feb 13, 2023, 4:01PM
Monday, February 06, 2023
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
Lara Goldstein
-
Feb 6, 2023, 12:09PM
Friday, February 03, 2023
PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
Lara Goldstein
-
Feb 3, 2023, 1:23PM
Tuesday, January 17, 2023
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More
Lara Goldstein
-
Jan 17, 2023, 6:38PM
Thursday, January 12, 2023
Psychedelics Company Revive Raises $3.2M To Target Infectious Diseases, Disorders
Lara Goldstein
-
Jan 12, 2023, 1:11PM
Monday, December 19, 2022
Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
Lara Goldstein
-
Dec 19, 2022, 8:23PM
Friday, December 16, 2022
Psyence, Revive Therapeutics Ink Private Placements: Capital To Support Drug Trials
Lara Goldstein
-
Dec 16, 2022, 4:46PM
Thursday, December 01, 2022
Revive Therapeutics To Raise Up To $5M Via Private Placement
Vuk Zdinjak
-
Dec 1, 2022, 9:27AM
Wednesday, November 30, 2022
Psychedelic Stock Gainers And Losers From November 30, 2022
Benzinga Insights
-
Nov 30, 2022, 4:30PM
Tuesday, November 29, 2022
Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Nov 29, 2022, 4:30PM
Monday, November 28, 2022
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Nov 28, 2022, 4:30PM
Friday, November 25, 2022
Psychedelic Stock Gainers And Losers From November 25, 2022
Benzinga Insights
-
Nov 25, 2022, 4:30PM
Thursday, November 24, 2022
Psychedelic Stock Gainers And Losers From November 24, 2022
Benzinga Insights
-
Nov 24, 2022, 4:30PM
Wednesday, November 23, 2022
Psychedelic Stock Gainers And Losers From November 23, 2022
Benzinga Insights
-
Nov 23, 2022, 4:30PM
Tuesday, November 22, 2022
Psychedelic Stock Gainers And Losers From November 22, 2022
Benzinga Insights
-
Nov 22, 2022, 4:30PM
Monday, November 21, 2022
Psychedelic Stock Gainers And Losers From November 21, 2022
Benzinga Insights
-
Nov 21, 2022, 4:30PM
Friday, November 18, 2022
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Nov 18, 2022, 4:30PM
Thursday, November 17, 2022
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Nov 17, 2022, 4:30PM
Wednesday, November 16, 2022
Psychedelic Stock Gainers And Losers From November 16, 2022
Benzinga Insights
-
Nov 16, 2022, 4:30PM
Tuesday, November 15, 2022
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Nov 15, 2022, 4:30PM
Thursday, November 10, 2022
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Nov 10, 2022, 4:34PM
Wednesday, November 09, 2022
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Nov 9, 2022, 3:41PM
Tuesday, November 08, 2022
Psychedelic Stock Gainers And Losers From November 8, 2022
Benzinga Insights
-
Nov 8, 2022, 3:34PM
Monday, November 07, 2022
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Nov 7, 2022, 4:48PM
Thursday, November 03, 2022
Psychedelic Stock Gainers And Losers From November 3, 2022
Benzinga Insights
-
Nov 3, 2022, 4:53PM
Wednesday, November 02, 2022
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Nov 2, 2022, 4:35PM
Thursday, October 27, 2022
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Oct 27, 2022, 4:33PM
Wednesday, October 26, 2022
Psychedelic Stock Gainers And Losers From October 26, 2022
Benzinga Insights
-
Oct 26, 2022, 4:31PM
Tuesday, October 25, 2022
Psychedelic Stock Gainers And Losers From October 25, 2022
Benzinga Insights
-
Oct 25, 2022, 4:48PM
Friday, October 21, 2022
Allied, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Oct 21, 2022, 5:18PM
Tuesday, October 18, 2022
Psychedelic Stock Gainers And Losers From October 18, 2022
Benzinga Insights
-
Oct 18, 2022, 4:50PM
Monday, October 17, 2022
Psychedelic Stock Gainers And Losers From October 17, 2022
Benzinga Insights
-
Oct 17, 2022, 4:55PM
Friday, October 14, 2022
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Oct 14, 2022, 4:43PM
Wednesday, October 12, 2022
Psychedelic Stock Gainers And Losers From October 12, 2022
Benzinga Insights
-
Oct 12, 2022, 6:01PM
Tuesday, October 11, 2022
Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Oct 11, 2022, 4:51PM
Monday, October 10, 2022
Psychedelic Stock Gainers And Losers From October 10, 2022
Benzinga Insights
-
Oct 10, 2022, 4:38PM
Thursday, October 06, 2022
Psychedelic Stock Gainers And Losers From October 6, 2022
Benzinga Insights
-
Oct 6, 2022, 4:32PM
Tuesday, October 04, 2022
Allied, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Oct 4, 2022, 5:09PM
Monday, October 03, 2022
Cybin, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Oct 3, 2022, 4:31PM
Friday, September 30, 2022
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Sep 30, 2022, 4:31PM
Thursday, September 29, 2022
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Sep 29, 2022, 4:55PM
Wednesday, September 28, 2022
Psychedelic Stock Gainers And Losers From September 28, 2022
Benzinga Insights
-
Sep 28, 2022, 4:58PM
Tuesday, September 27, 2022
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Sep 27, 2022, 4:41PM
Monday, September 26, 2022
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Sep 26, 2022, 4:32PM
Friday, September 23, 2022
Will Cannabis Entrepreneurs Switch To Psychedelics?
Andrew Ward
-
Sep 23, 2022, 10:47AM
Thursday, September 22, 2022
Psychedelic Stock Gainers And Losers From September 22, 2022
Benzinga Insights
-
Sep 22, 2022, 4:33PM
Wednesday, September 21, 2022
Psychedelic Stock Gainers And Losers From September 21, 2022
Benzinga Insights
-
Sep 21, 2022, 4:35PM
Show more